Down 65% From Its 52-Week High, Is Viking Therapeutics Stock a Bargain Buy?
Viking Therapeutics (NASDAQ: VKTX) is a promising growth stock with a strong GLP-1 drug candidate in VK2735, which may ...
1 Biotech Stock Down 52% That Could Soar by 233%, According to Wall Street
Viking Therapeutics stock is down 52% over the trailing-12-month period. However, many Wall Street analysts remain ...
Market Whales and Their Recent Bets on VKTX Options
Currently trading with a volume of 1,145,610, the VKTX's price is down by -1.23%, now at $28.0. RSI readings suggest the ...
Viking Therapeutics’ new contract is a game changer. Here’s how much money it could bring in.
Viking Therapeutics Inc.’s stock soared 8% Wednesday, after the maker of a promising weight-loss pill secured a manufacturing ...
Viking Therapeutics: Finally, Here Comes The Buying Opportunity (Upgrade)
Viking Therapeutics remains speculative despite progress in its clinical portfolio, notably the VK2735 program for obesity.
Viking Therapeutics Is Ready For A Standalone Future
Viking announced a supply deal with CordenPharma that sets it up for a standalone path to the obesity market. Read why I ...
Viking Therapeutics closer to bringing its Ozempic competitor to market
Viking Therapeutics (VKTX), the developer of a promising experimental weight-loss drug, has announced a multi-year ...
Viking Therapeutics (NasdaqCM:VKTX) Soars 10% With CordenPharma Manufacturing Agreement
Viking Therapeutics (NasdaqCM:VKTX) experienced a share price increase of 10% last week, coinciding with the announcement of a multi-year manufacturing agreement with CordenPharma for its V2735 ...
Truist Financial Sticks to Its Buy Rating for Viking Therapeutics (VKTX)
In a report released today, Joon Lee from Truist Financial maintained a Buy rating on Viking Therapeutics (VKTX – Research Report). The ...
Nasdaq2d
Market Whales and Their Recent Bets on VKTX Options
Investors with a lot of money to spend have taken a bearish stance on Viking Therapeutics (NASDAQ:VKTX). And retail traders should know. We noticed this today when the trades showed up on publicly ...
Morningstar11d
Viking Therapeutics' new contract is a game changer. Here's how much money it could bring in.
San Diego-based Viking (VKTX) said Tuesday it has signed a broad manufacturing agreement with CordenPharma, a privately held Swiss company, to support the commercialization of its oral obesity ...